These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 28325710)

  • 21. Take-home emergency naloxone to prevent deaths from heroin overdose.
    Strang J; Bird SM; Dietze P; Gerra G; McLellan AT
    BMJ; 2014 Nov; 349():g6580. PubMed ID: 25378248
    [No Abstract]   [Full Text] [Related]  

  • 22. Randomized controlled pilot trial of naloxone-on-release to prevent post-prison opioid overdose deaths.
    Parmar MK; Strang J; Choo L; Meade AM; Bird SM
    Addiction; 2017 Mar; 112(3):502-515. PubMed ID: 27776382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Take-home naloxone to reduce heroin death.
    Baca CT; Grant KJ
    Addiction; 2005 Dec; 100(12):1823-31. PubMed ID: 16367983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strategies for preventing heroin overdose.
    Sporer KA
    BMJ; 2003 Feb; 326(7386):442-4. PubMed ID: 12595388
    [No Abstract]   [Full Text] [Related]  

  • 25. Wasted, overdosed, or beyond saving--to act or not to act? Heroin users' views, assessments, and responses to witnessed overdoses in Malmö, Sweden.
    Richert T
    Int J Drug Policy; 2015 Jan; 26(1):92-9. PubMed ID: 25130869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medical providers' knowledge and concerns about opioid overdose education and take-home naloxone rescue kits within Veterans Affairs health care medical treatment settings.
    Winograd RP; Davis CS; Niculete M; Oliva E; Martielli RP
    Subst Abus; 2017; 38(2):135-140. PubMed ID: 28486076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal in Russian cities.
    Coffin PO; Sullivan SD
    J Med Econ; 2013 Aug; 16(8):1051-60. PubMed ID: 23730942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brief overdose education is sufficient for naloxone distribution to opioid users.
    Behar E; Santos GM; Wheeler E; Rowe C; Coffin PO
    Drug Alcohol Depend; 2015 Mar; 148():209-12. PubMed ID: 25595053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Awareness, Possession, and Use of Take-Home Naloxone Among Illicit Drug Users, Vancouver, British Columbia, 2014-2015.
    Nolan S; Buxton J; Dobrer S; Dong H; Hayashi K; Milloy MJ; Kerr T; Montaner J; Wood E
    Public Health Rep; 2017; 132(5):563-569. PubMed ID: 28750193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Distribution of naloxone to prevent death from heroin overdose. Study of opioid dependent patients' attitudes to be part of the antidote program].
    Håkansson A; Vedin A; Wallin C; Kral AH
    Lakartidningen; 2013 Jul 17-Aug 6; 110(29-31):1340-2. PubMed ID: 23980443
    [No Abstract]   [Full Text] [Related]  

  • 31. Preliminary evidence of health care provider support for naloxone prescription as overdose fatality prevention strategy in New York City.
    Coffin PO; Fuller C; Vadnai L; Blaney S; Galea S; Vlahov D
    J Urban Health; 2003 Jun; 80(2):288-90. PubMed ID: 12791804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Challenges with take-home naloxone in reducing heroin mortality: a review of fatal heroin overdose cases in Victoria, Australia.
    Stam NC; Gerostamoulos D; Smith K; Pilgrim JL; Drummer OH
    Clin Toxicol (Phila); 2019 May; 57(5):325-330. PubMed ID: 30451007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heroin and naloxone.
    Lagoy A
    Am J Nurs; 2014 Oct; 114(10):12. PubMed ID: 25251107
    [No Abstract]   [Full Text] [Related]  

  • 34. Take-Home Naloxone and the Prevention of Deaths from Heroin Overdose: Pursuing Strong Science, Fuller Understanding, Greater Impact.
    Strang J
    Eur Addict Res; 2022; 28(3):161-175. PubMed ID: 34963112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Naloxone-Induced Withdrawal in Individuals With and Without Fentanyl-Positive Urine Samples.
    Jones JD; Sherwin E; Martinez S; Comer SD
    Am J Addict; 2020 Jan; 29(1):51-56. PubMed ID: 31782591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High uptake of naloxone-based overdose prevention training among previously incarcerated syringe-exchange program participants.
    Barocas JA; Baker L; Hull SJ; Stokes S; Westergaard RP
    Drug Alcohol Depend; 2015 Sep; 154():283-6. PubMed ID: 26143300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment for deaths in out-of-hospital heroin overdose patients treated with naloxone who refuse transport.
    Vilke GM; Sloane C; Smith AM; Chan TC
    Acad Emerg Med; 2003 Aug; 10(8):893-6. PubMed ID: 12896894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distribution of naloxone for overdose prevention to chronic pain patients.
    Coe MA; Walsh SL
    Prev Med; 2015 Nov; 80():41-3. PubMed ID: 26024850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Take -home naloxone rescue kits following heroin overdose in the emergency department to prevent opioid overdose related repeat emergency department visits, hospitalization and death- a pilot study.
    Papp J; Vallabhaneni M; Morales A; Schrock JW
    BMC Health Serv Res; 2019 Dec; 19(1):957. PubMed ID: 31829228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Naloxone distribution and possession following a large-scale naloxone programme.
    Madah-Amiri D; Gjersing L; Clausen T
    Addiction; 2019 Jan; 114(1):92-100. PubMed ID: 30129078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.